Search

everythinglearnresearchcommunity

for

Search:↓

IGF-I promotes hair growth by keeping hair follicles in the growth phase longer.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

SCD1 is crucial for skin health and overall energy balance.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The woman had a genetic condition causing high cortisol and androgen levels, treatable with dexamethasone.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Rat hair follicles grow longer in vitro, but certain factors can inhibit this growth.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Early balding linked to higher heart disease risk.

mIGF-1 in skin cells speeds up wound healing and hair growth in mice without harmful effects.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.